Characterization of novel and uncharacterized p53 SNPs in the Chinese population--intron 2 SNP co-segregates with the common codon 72 polymorphism
- PMID: 21249215
- PMCID: PMC3018411
- DOI: 10.1371/journal.pone.0015320
Characterization of novel and uncharacterized p53 SNPs in the Chinese population--intron 2 SNP co-segregates with the common codon 72 polymorphism
Abstract
Multiple single nucleotide polymorphisms (SNPs) have been identified in the tumor suppressor gene p53, though the relevance of many of them is unclear. Some of them are also differentially distributed in various ethnic populations, suggesting selective functionality. We have therefore sequenced all exons and flanking regions of p53 from the Singaporean Chinese population and report here the characterization of some novel and uncharacterized SNPs - four in intron 1 (nucleotide positions 8759/10361/10506/11130), three in intron 3 (11968/11969/11974) and two in the 3'UTR (19168/19514). Allelic frequencies were determined for all these and some known SNPs, and were compared in a limited scale to leukemia and lung cancer patient samples. Intron 2 (11827) and 7 (14181/14201) SNPs were found to have a high minor allele frequency of between 26-47%, in contrast to the lower frequencies found in the US population, but similar in trend to the codon 72 polymorphism (SNP12139) that shows a distribution pattern correlative with latitude. Several of the SNPs were linked, such as those in introns 1, 3 and 7. Most interestingly, we noticed the co-segregation of the intron 2 and the codon 72 SNPs, the latter which has been shown to be expressed in an allele-specific manner, suggesting possible regulatory cross-talk. Association analysis indicated that the T/G alleles in both the co-segregating intron 7 SNPs and a 4tagSNP haplotype was strongly associated increased susceptibility to lung cancer in non-smoker females [OR: 1.97 (1.32, 3.394)]. These data together demonstrate high SNP diversity in p53 gene between different populations, highlighting ethnicity-based differences, and their association with cancer risk.
Conflict of interest statement
Figures
Similar articles
-
Correlation Between SNPs at the 3'UTR of the FGF2 Gene and Their Interaction with Environmental Factors in Han Chinese Diabetic Peripheral Neuropathy Patients.J Mol Neurosci. 2021 Feb;71(2):203-214. doi: 10.1007/s12031-020-01641-5. Epub 2020 Jul 1. J Mol Neurosci. 2021. PMID: 32613556
-
TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study.Arthritis Res Ther. 2011 Mar 11;13(2):R41. doi: 10.1186/ar3277. Arthritis Res Ther. 2011. PMID: 21396113 Free PMC article.
-
Association of miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population.Acta Biochim Biophys Sin (Shanghai). 2014 Feb;46(2):149-54. doi: 10.1093/abbs/gmt138. Epub 2013 Dec 26. Acta Biochim Biophys Sin (Shanghai). 2014. PMID: 24374662
-
[Association of the exon 8 and intron 8 polymorphisms of the human urate transporter 1 gene with primary hyperuricemia in Chinese Han population].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Dec;27(6):659-63. doi: 10.3760/cma.j.issn.1003-9406.2010.06.012. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010. PMID: 21154327 Chinese.
-
Association of TP53 polymorphisms with primary open-angle glaucoma: a meta-analysis.Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3756-63. doi: 10.1167/iovs.12-9818. Invest Ophthalmol Vis Sci. 2012. PMID: 22562509 Review.
Cited by
-
p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.PLoS One. 2012;7(9):e45820. doi: 10.1371/journal.pone.0045820. Epub 2012 Sep 24. PLoS One. 2012. PMID: 23029260 Free PMC article.
-
Biosafety evaluation of culture-expanded human chondrocytes with growth factor cocktail: a preclinical study.Sci Rep. 2020 Dec 9;10(1):21583. doi: 10.1038/s41598-020-78395-y. Sci Rep. 2020. PMID: 33299022 Free PMC article.
References
-
- Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Review. Oncogene. 2002;26(15):2157–2165. - PubMed
-
- Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002;2:594–604. - PubMed
-
- Brosh R, Rotter V. When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer. 2009;9(10):701–713. - PubMed
-
- Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296–299. - PubMed
-
- Watanabe T, Ichikawa A, Saito H, Hotta T. Overexpression of the MDM2 oncogene in leukemia and lymphoma. Leuk Lymphoma. 1996;21:391–397. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous